Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 2
1(20.0%)
5Total
N/A(4)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT01911195Not ApplicableCompleted

Reconstructing Consciousness and Cognition

Role: collaborator

NCT03216356Phase 2Withdrawn

Effect of D-cycloserine on a Short Imagery Rescripting Intervention for Subclinical PTSD

Role: collaborator

NCT04589377Not ApplicableCompleted

Mindfulness to Mitigate Psychological Threat and Improve Engagement and Learning in Introductory Physics Courses

Role: collaborator

NCT02761330Not ApplicableCompleted

Cognitive Recovery After Electroconvulsive Therapy and General Anesthesia

Role: collaborator

NCT02292251Not ApplicableCompleted

Study to Enhance Motor Acute Recovery With Intensive Training After Stroke

Role: collaborator

All 5 trials loaded